Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

9amHealth vs Hims

9amHealth and Hims sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed

9amHealth

5.1
★★★☆☆2.6/5
Visit 9amHealth →
VS
Hims logo

Hims

6.8
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC

Visit Hims →

If you are choosing between 9amHealth and Hims, price alone will not settle it. Hims leads our six-part score, 6.8 to 5.1. One of the two has an FDA warning letter on record, covered below.

9amHealth vs Hims price

Hims publishes $199 a month. 9amHealth does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

Hims lists semaglutide and tirzepatide; 9amHealth does not name its drug.

On format, 9amHealth posts no priced format, while Hims prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.

Where each one treats patients

9amHealth does not publish where it ships, and Hims lists 50 states.

Pricing

9amHealth

Membership (self-pay; free w/ insurance)Brand-name
$149/mo
semaglutide

Hims

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)

What each price covers

Hims' price also covers the medication itself, which 9amHealth does not claim.

9amHealth does not say what its price includes.

Hims is silent on shipping and lab work.

That matters most for the drug: unless 9amHealth confirms otherwise, budget for medication on top of its listed price.

9amHealth

Inclusions not disclosed.

Hims

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Where each one scores higher

Overall, Hims scores 6.8 and 9amHealth 5.1 out of 10.

9amHealth is stronger on support (5.0 vs 3.0).

Hims is stronger on effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0), trust & safety (7.0 vs 4.0) and accessibility (10.0 vs 5.0).

Value is within half a point.

How we score

9amHealth

5.1/10

Overall

Hims

6.8/10

Value25%

3.0A
vs
B
3.0

Effectiveness25%

9.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

4.0A
vs
B
7.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

5.0A
vs
B
3.0

FDA warning letters

The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.

9amHealth has no FDA warning letter on record with us.

Features & Coverage

Feature9amHealthHims
Starting PriceNot published$199/mo
Features✓7 features2 features
States AvailableNot disclosed50
Compounded—✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning Letters✓None1 letter

About 9amHealth

Membership costs $149/month, or nothing at all where insurance picks it up, and that covers specialist visits, labs, lifestyle support and the medications themselves. 9am Health treats cardiometabolic health broadly, with weight management handled through branded GLP-1s that carry FDA approval, Wegovy, Zepbound and Saxenda, alongside FDA-approved generics. Physicians, obesity specialists board-certified as DABOM, endocrinologists, dietitians and pharmacists make up the team, which also works employer and state-plan partnerships to help patients through insurance.

Read our full 9amHealth review →

About Hims

Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.

Read our full Hims review →

Pros & Cons

9amHealth

What we like

  • We found no FDA warning letters issued to 9amHealth

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Hims

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states
  • Names 4 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Hims

Hims wins this one, 6.8 to 5.1, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC.

Choose 9amHealth if…

You want broader feature coverage.

Choose Hims if…

You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.4

Trimi Health

Knowing which pharmacy fills the vial: it names VialsRx

6.4

ShedRx

Oral orforglipron alongside the injectables

9.0

bmiMD

Starting below a standard dose, with microdose tiers

9amHealth vs Hims: FAQ

Only Hims publishes a price ($199 a month). 9amHealth quotes after sign-up.
No. 9amHealth lists no named drug; Hims lists semaglutide and tirzepatide.
9amHealth does not publish where it ships; Hims lists 50 states. Confirm your state before paying.
Only Hims includes the medication itself.
9amHealth has none. Hims has an open FDA warning letter from September 9, 2025.
No. Neither 9amHealth nor Hims pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.